Home > Insider Trading > Filing (0001628280-21-010022)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1600620	Aurinia Pharmaceuticals Inc.	AUPH	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1363683	Peter Greenleaf	#1203-4464 Markham Street Victoria A1 V8Z7X8	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-05-11	2,133	$10.15	10,461	No	4	P	Direct
Common Stock	Acquisiton	2021-05-11	2,992	$11.11	13,453	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Footnotes

The price in column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $9.74 to $10.64, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
The price in column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $10.91 to $11.275, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.